drugset / Trial / NCT04056728
A Phase IV Study to Assess the Safety of EupentaTM Inj
NaSingle-groupOpen-labelPrevention
Summary
A prospective, open-label, interventional phase IV study to assess the safety of EupentaTM Inj.{fully liquid pentavalent vaccine, Adsorbed Diphtheria-Tetanus-whole-cell Pertussis-Hepatitis B (rDNA \[recombinant-deoxyribonucleic acid\])-Haemophilus influenzae type b conjugate vaccine}
Timeline
- Start
- 2019-09-23
- Primary completion
- 2020-10-12
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eupenta | Vaccine | 0.5 ml | — |